Wilmington Savings Fund Society, FSB
Position in RPRX — Royalty Pharma plc
CIK 900974
WILMINGTON, DE
Position in RPRX
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$6,080,566
+$1,057,484 QoQ
Shares Held
108,446
+3.6% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#196
of 641 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Wilmington Savings Fund Society, FSB holds $11,168,948 across 32 Biotechnology names. RPRX ranks #1 (54.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
This page
|
108,446 | $6,080,566 | |
| 2 | ABSI |
Absci Corp
|
189,522 | $2,196,559 | |
| 3 | TECH |
BIO-TECHNE Corp
|
28,159 | $1,989,433 | |
| 4 | ARGX |
Argenx SE
|
239 | $221,736 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
370 | $183,789 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
393 | $146,066 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
106 | $66,095 | |
| 8 | CLDX |
Celldex Therapeutics, Inc.
|
1,633 | $60,763 |
All Filings in RPRX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,080,566 | 108,446 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $5,023,082 | 104,713 | Shares | Defined | 2026-04-30 | |
| 2025-12-31 | $4,019,371 | 104,021 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $3,682,103 | 104,368 | Shares | Defined | 2025-11-20 | |
| 2025-06-30 | $3,871,351 | 107,448 | Shares | Defined | 2025-07-28 | |
| 2025-03-31 | $3,389,309 | 108,876 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $20,612 | 808 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $61,389 | 2,170 | Shares | Defined | 2024-11-25 | |
| No filing history on record for this holder in this stock. | ||||||